PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research
Cannabis Law Report
OCTOBER 15, 2021
RespRx, in addition to its clinical research with COPD, has been engaged in select, non-clinical trials to treat cancer and demonstrated effectiveness. Learn more about USMJ’s ecommerce site at www.usmj.com. In conjunction with PAOG’s ongoing IND initiative for RespRx, and PAOG’s connection with U.S. Billion by 2027.
Let's personalize your content